Search Videos and More


Liver Cancer and Hepatic Arterial Infusion Pump Chemotherapy News

Liver Cancer and Hepatic Arterial Infusion Pump Chemotherapy

Fox Chase Cancer Center is renowned for its use of the latest treatment methods for a range of liver and related cancers.
Fox Chase Recruiting for Ongoing Phase-1 Trial of Targeted Therapy for Ewing Sarcoma News

Fox Chase Recruiting for Ongoing Phase-1 Trial of Targeted Therapy for Ewing Sarcoma

The phase-1 trial will test a new targeted therapy called seclidemstat in patients with relapsed or refractory Ewing sarcoma or Ewing-related Sarcomas.
Clinical Nurse Manager, Rebecca Farrell, MSN, RN, Keeps Calm, Carries On Amidst COVID-19 Pandemic News

Clinical Nurse Manager, Rebecca Farrell, MSN, RN, Keeps Calm, Carries On Amidst COVID-19 Pandemic

As patient care adapted to the restrictions of the COVID-19 pandemic, Farrell continued to ensure that patients had access to cutting-edge care.
Identification and Management of Immunotherapy Toxicities News

Identification and Management of Immunotherapy Toxicities

The NCCN and ASCO have developed new guidelines that describe which bodily systems can be affected by immunotherapy and how to manage side effects based on their severity.
Multidisciplinary Care, Specialized Clinicians Necessary for Recurrent Sarcoma Treatment News

Multidisciplinary Care, Specialized Clinicians Necessary for Recurrent Sarcoma Treatment

With so many different kinds of sarcoma that can be easily misdiagnosed in settings where they aren’t frequently seen, Fox Chase’s expertise in sarcoma care and its multidisciplinary team approach provide patients with more treatment options.?
PARP Inhibitors Now Used for First- and Second-Line Maintenance of Ovarian Cancer News

PARP Inhibitors Now Used for First- and Second-Line Maintenance of Ovarian Cancer

The use of PARP inhibitors has changed the way ovarian cancer is treated and has improved outcomes.
Cancer Prediction Models May Provide False Sense of Reliability for Guiding Care News

Cancer Prediction Models May Provide False Sense of Reliability for Guiding Care

Over the last decade, dozens of predictive models have been developed to improve on the ability of stage, grade and type to predict recurrence. Unfortunately, many of the prediction models used by clinicians to guide patient care and clinical trial selection for solid tumors may not be as accurate as they are thought to be, according to a new study by researchers at Fox Chase Cancer Center.